HER2 Activation Factors in Arsenite-Exposed Bladder Epithelial Cells

Area of Science:

• Environmental Health
• Oncology
• Molecular Biology

Background:

• Chronic arsenic exposure in drinking water is linked to increased bladder cancer risk globally.
• Human epidermal growth factor receptor 2 (HER2) is implicated in bladder cancer development.
• Mechanisms of HER2 activation in arsenite-exposed urothelial cells remain largely unknown.

Purpose of the Study:

• To investigate factors associated with HER2 activation in an arsenite-exposed human bladder epithelial cell line.
• To elucidate the molecular mechanisms underlying HER2 activation by arsenite.

Main Methods:

• Treatment of human bladder epithelial cells with arsenite.
• Analysis of protein levels and phosphorylation status of HER2 and related signaling molecules using Western blotting and other biochemical assays.
• Manipulation of specific protein levels using neutralizing antibodies, siRNA, and inhibitors.

Main Results:

• Arsenite exposure significantly increased HER2 phosphorylation.
• Elevated levels of EGF, TGFα, sE-cad, and NRG1 were observed in arsenite-treated cells.
• HSP90 and PMCA2 levels increased, while IL-6 and NDRG1 levels decreased.
• Exogenous EGF, TGFα, NRG1, and HSP90 promoted HER2 phosphorylation, while IL-6 and NDRG1 suppressed it.
• Reduction of EGF, TGFα, NRG1, PMCA2, or HSP90 suppressed HER2 phosphorylation, whereas E-cadherin knockdown promoted it.

Conclusions:

• Arsenite exposure activates HER2 in bladder epithelial cells through complex signaling pathways.
• HER2 activation involves promoting dimerization, stabilizing phosphorylated HER2, and overcoming suppressive mechanisms.
• Findings provide insights into the role of HER2 in arsenic-induced bladder carcinogenesis.